• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

350
64
46
44
20

COUNTRY

43
11
5
5
4

PRICE

176
451
667
1,244

PUBLISHED

34
158
388
1,244

PRODUCT TYPE

1,212
17
11
4

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded...

May 2014
FROM

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD...

May 2014
FROM

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded...

May 2014
FROM

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a...

May 2014
FROM

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded...

May 2014
FROM

PharmaPoint: Major Depressive Disorder - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: Major Depressive Disorder - Japan Drug Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market...

May 2014
FROM

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is...

May 2014
FROM

PharmaPoint: Major Depressive Disorder - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Major Depressive Disorder - US Drug Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market...

May 2014
FROM

Abdominal Pain Global Clinical Trials Review, H1, 2014

Abdominal Pain Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Abdominal Pain Global Clinical Trials Review, H1, 2014" provides data on the Abdominal Pain clinical trial...

May 2014
FROM

Batten Disease Global Clinical Trials Review, H1, 2014

Batten Disease Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Batten Disease Global Clinical Trials Review, H1, 2014" provides data on the Batten Disease clinical trial...

May 2014
FROM

Cervical Dystonia Global Clinical Trials Review, H1, 2014

Cervical Dystonia Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Cervical Dystonia Global Clinical Trials Review, H1, 2014" provides data on the Cervical Dystonia clinical...

May 2014
FROM

Cerebral Vasospasm Global Clinical Trials Review, H1, 2014

Cerebral Vasospasm Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Cerebral Vasospasm Global Clinical Trials Review, H1, 2014" provides data on the Cerebral Vasospasm clinical...

May 2014
FROM

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, H1, 2014

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global...

May 2014
FROM

Acute Back Pain Global Clinical Trials Review, H1, 2014

Acute Back Pain Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Acute Back Pain Global Clinical Trials Review, H1, 2014" provides data on the Acute Back Pain clinical trial...

May 2014
FROM

Age Related Memory Impairment Global Clinical Trials Review, H1, 2014

Age Related Memory Impairment Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Age Related Memory Impairment Global Clinical Trials Review, H1, 2014" provides data on the...

May 2014
FROM

Carotid Sinus Syncope Global Clinical Trials Review, H1, 2014

Carotid Sinus Syncope Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Carotid Sinus Syncope Global Clinical Trials Review, H1, 2014" provides data on the Carotid Sinus...

May 2014
FROM

Chorea Global Clinical Trials Review, H1, 2014

Chorea Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Chorea Global Clinical Trials Review, H1, 2014" provides data on the Chorea clinical trial scenario. This report...

May 2014
FROM

Cancer Anorexia Global Clinical Trials Review, H1, 2014

Cancer Anorexia Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Cancer Anorexia Global Clinical Trials Review, H1, 2014" provides data on the Cancer Anorexia clinical trial...

May 2014
FROM

Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2014

Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2014" provides data on the Acute Spinal...

May 2014
FROM

Bulimia Nervosa Global Clinical Trials Review, H1, 2014

Bulimia Nervosa Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Bulimia Nervosa Global Clinical Trials Review, H1, 2014" provides data on the Bulimia Nervosa clinical trial...

May 2014
FROM
Loading Indicator

Our Clients

Our clients' logos